Average Co-Inventor Count = 3.00
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alkermes Controlled Therapeutics, Inc. Ii (15 from 36 patents)
2. Alkermes Pharma Ireland Limited (8 from 160 patents)
3. Alkermes, Inc. (8 from 75 patents)
4. Cerulean Pharma Inc. (6 from 21 patents)
5. Alkermes Controlled Therapeutics, Inc. (4 from 46 patents)
6. Novartis Ag (1 from 3,923 patents)
7. Janssen Pharmaceutica (1 from 32 patents)
8. Placon Therapeutics, Inc. (1 from 11 patents)
9. Alkermes Controlled Therapeutics, Inc. I (1 from 1 patent)
44 patents:
1. 11464871 - Methods and systems for polymer precipitation and generation of particles
2. 10342801 - Platinum compounds, compositions, and uses thereof
3. 10328070 - Polymorphic forms of naltrexone
4. 10166228 - Polymorphic forms of naltrexone
5. 9980958 - Polymorphic forms of naltrexone
6. 9827240 - Polymorphic forms of naltrexone
7. 9598503 - Methods and systems for polymer precipitation and generation of particles
8. 9556189 - Polymorphic forms of naltrexone
9. 9365580 - Polymorphic forms of naltrexone
10. 9221830 - Polymorphic forms of naltrexone
11. 8975272 - Polymorphic forms of naltrexone
12. 8809492 - Method for fabricating nanoparticles
13. 8735420 - Polymorphic forms of naltrexone
14. 8618240 - Methods and systems for generating nanoparticles
15. 8546521 - Method for fabricating nanoparticles